Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Sanofi will spend $340 million to expand its biologics production site in Geel, Belgium. The French drug company already makes active ingredients for enzyme replacement therapies there. Additional capacity along with new process and quality control labs will support Sanofi’s monoclonal antibody development pipeline. Sanofi and its Genzyme biologics business have already invested $680 million at the 15-year-old site.
This article has been sent to the following recipient: